Development and Validation of the Promising PPAR Signaling Pathway-Based Prognostic Prediction Model in Uterine Cervical Cancer

Identification of the novel therapeutic targets and biomarkers associated of prostate cancer with cancer-associated fibroblasts (CAFs)

(2023) Xinyu Zhai et al.   Frontiers in Oncology

Low concentration triphenyl phosphate fuels proliferation and migration of hepatocellular carcinoma cells

(2022) Liang Ye et al.   ENVIRONMENTAL TOXICOLOGY

Identifying tumor antigens and immune subtypes of gastrointestinal MALT lymphoma for immunotherapy development

(2022) Xinlu Jiang et al.   Frontiers in Oncology

Glitazones, PPAR-γ and Neuroprotection

(2021) Ashwini Prem Kumar et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions

(2021) Giuseppe Ercolano et al.   Nature Communications

Pharmacophore based in silico study with laboratory verification—environmental explanation of prostate cancer recurrence

(2021) Tongtong Zhang et al.   ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH

Why not de-intensification for uterine cervical cancer?

(2021) Naoya Murakami et al.   GYNECOLOGIC ONCOLOGY

PPAR control of metabolism and cardiovascular functions

(2021) David Montaigne et al.   Nature Reviews Cardiology

Pyrethroids Toxicity to Male Reproductive System and Offspring as a Function of Oxidative Stress Induction: Rodent Studies

(2021) Xu Zhang et al.   Frontiers in Endocrinology

The Role of PPAR-γ in Allergic Disease

(2021) Julian M. Stark et al.   CURRENT ALLERGY AND ASTHMA REPORTS

The comprehensive analysis based study of perfluorinated compounds—Environmental explanation of bladder cancer progression

(2021) Shaopei Ye et al.   ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY

Use of Smartphones for the Detection of Uterine Cervical Cancer: A Systematic Review

(2021) Denisse Champin et al.   Cancers

Evaluation of uterine cervical cancer in pregnancy: A cross-sectional study

(2020) Rafaela B. Vasques et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions

(2020) Masahiro Kagabu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The role of Peroxisome Proliferator-Activated Receptors (PPAR) in immune responses

(2020) Anthos Christofides et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Early-life exposure to bisphenol A and reproductive-related outcomes in rodent models: a systematic review and meta-analysis

(2020) Xiaohan Ren et al.   Aging-US

PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer

(2020) Masahiro Shimomura et al.   Oncology Letters

Diagnosing uterine cervical cancer on a single T2-weighted image: Comparison between deep learning versus radiologists

(2020) Aiko Urushibara et al.   EUROPEAN JOURNAL OF RADIOLOGY

Radiation therapy for elderly patients with uterine cervical cancer: feasibility of curative treatment

(2019) Masaharu Hata   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

PPAR Agonists and Metabolic Syndrome: An Established Role?

(2018) Margherita Botta et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Fatty acids, eicosanoids and PPAR gamma

(2016) Rachel Marion-Letellier et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Fertility-sparing surgery for uterine cervical cancer

(2016) Seiya Sato et al.   Future Oncology

Uterine Cervical Cancer Displaying Tumor-Related Leukocytosis: A Distinct Clinical Entity With Radioresistant Feature

(2014) S. Mabuchi et al.   JNCI-Journal of the National Cancer Institute